Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引:3
|
作者
Gulpen, Anouk J. W. [1 ,2 ,3 ]
Braeken, Dionne C. W. [1 ]
Schalla, Simon [2 ,4 ]
Ten Cate, Hugo [1 ,2 ,3 ]
Crijns, Harry J. [2 ,4 ]
Ten Cate-Hoek, Arina J. [1 ,2 ]
机构
[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands
关键词
Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;
D O I
10.1159/000524094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [21] Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
    Komen, Joris J.
    Heerdink, Eibert R.
    Klungel, Olaf H.
    Mantel-Teeuwisse, Aukje K.
    Forslund, Tomas
    Wettermark, Bjorn
    Hjemdahl, Paul
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (F11) : F72 - F80
  • [22] Electronic and self-reported adherence to direct oral anticoagulants in patients with atrial fibrillation
    Kolmanova, E.
    Dvorackova, S.
    Voriskova, E.
    Sisakova, M.
    Brabec, M.
    Kala, P.
    Penka, M.
    Mala-Ladova, K.
    Maly, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1547 - 1547
  • [23] Mild anxiety disorders impact on atrial fibrillation patients' direct oral anticoagulants adherence
    Bogdanova, R. S.
    Schekochikhin, D. Y.
    Kopylov, P. Y.
    Belova, S. S.
    Ovsyannikova, V. V.
    Gognieva, D. G.
    Volel, B. A.
    Smulevich, A. B.
    Syrkin, A. L.
    Mukhorina, A. K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 311 - 311
  • [24] Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
    Yu, Hee Tae
    Yang, Pil-Sung
    Jang, Eunsun
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Lip, Gregory Y. H.
    Joung, Boyoung
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (12):
  • [25] Adherence with direct oral anticoagulants in patients with atrial fibrillation: Trends, risk factors, and outcomes
    Arbel, Anat
    Abu-Ful, Zomoroda
    Preis, Meir
    Cohen, Shai
    Saliba, Walid
    JOURNAL OF ARRHYTHMIA, 2022, 38 (01) : 67 - 76
  • [26] Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation
    Alexandros Briasoulis
    Amgad Mentias
    Alexander Mazur
    Paulino Alvarez
    Enrique C. Leira
    Mary S. Vaughan Sarrazin
    Cardiovascular Drugs and Therapy, 2021, 35 : 261 - 272
  • [27] COMPARATIVE EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
    Done, N.
    Li, D.
    Woolley, A.
    Rose, A. J.
    Prentice, J. C.
    VALUE IN HEALTH, 2018, 21 : S6 - S7
  • [28] Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation
    Briasoulis, Alexandros
    Mentias, Amgad
    Mazur, Alexander
    Alvarez, Paulino
    Leira, Enrique C.
    Vaughan Sarrazin, Mary S.
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (02) : 261 - 272
  • [29] Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
    Shah, Surbhi
    Norby, Faye L.
    Datta, Yvonne H.
    Lutsey, Pamela L.
    MacLehose, Richard F.
    Chen, Lin Y.
    Alonso, Alvaro
    BLOOD ADVANCES, 2018, 2 (03) : 200 - 209
  • [30] Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study
    Chen, Pei-Ti
    Wang, Tsae-Jyy
    Hsieh, Ming-Hsiung
    Liu, Ju-Chi
    Liu, Chieh-Yu
    Wang, Kwua-Yun
    Laio, Wen-Chun
    BMJ OPEN, 2019, 9 (09):